Patients Transforming US healthcare into a whole person care system Of the US healthcare system’s innumerable problems, three in particular stand out as the biggest priorities to address.
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
